Pfizer's COVID-19 vaccine for children under five may lose FDA authorization, leading to potential supply shortages. Modern ...

W hen BioNTech agreed to acquire rival messenger RNA company CureVac in a $1.25 billion stock deal earlier this summer, some ...

NIH Director Jay Bhattacharya offered an explanation for the cancellation of mRNA vaccine contracts that didn't align with ...

Adams, who served as surgeon general during the first Trump administration, said Kennedy's assertions about the efficacy of ...

Robert F. Kennedy Jr. has announced that his department will end funding for a series of mRNA-based vaccines aimed at ...

CureVac ( (CVAC)) has provided an announcement. On August 7, 2025, CureVac announced the resolution of U.S. patent litigation with Pfizer/BioNTech concerning mRNA-based COVID-19 vaccines. As part of ...

GSK (NYSE:GSK) (LON:GSK) said on Monday that the U.S. Food and Drug Administration has accepted its priority review ...

CDC staffers are voicing frustration over RFK Jr.’s past vaccine comments, following Friday’s shooting at the agency’s ...

Note that some links may require registration or subscription. DermaRite Industries is recalling certain lots of its over-the ...

Shares of several biotech firms fell in premarket trading Monday after reports that ousted U.S. Food and Drug Administration ...

Are women somehow missing from the future of innovation? New research suggests that gender bias may be quietly shaping the ...

This episode of Pharma Pulse explores the FDA’s new proactive quality review initiative for drug manufacturing, GSK’s $370 ...